Cream Cheese Recall Listeria: FDA Upgrades Recall to Class I, Citing Risk of ‘Serious Adverse Health Consequences or Death’
The Cream Cheese Recall Listeria designation landed in the federal spotlight after the U. S. Food and Drug Administration upgraded the ongoing recall to its most serious risk classification, Class I. The move follows internal testing by the manufacturer that found possible contamination with Listeria monocytogenes in multiple flavors of cream cheese sold in 5-pound white plastic tubs with expiration dates through February 27, 2026.
Background and context: what the upgrade means
Made Fresh Salads, Inc. initiated the recall on February 19; an FDA enforcement notice tied to testing published on February 20 identified potential contamination. On March 11, the FDA set the recall at Class I, the agency’s highest level, indicating it believes there is “a reasonable probability” that consumption could cause “serious adverse health consequences or death. ” The recalled products were distributed by direct delivery to retail stores and distributors in Brooklyn, Queens, the Bronx, and the New York City area.
Deep analysis: contamination, distribution and public risk
The company identified the likely source as a contaminated part of a mixer used during production and removed that part from service. The manufacturing detail narrows the vector but does not eliminate downstream risk for consumers who already bought the product. The recalled tubs were sold under the Made Fresh Salads label in 5-pound white plastic containers with expiration dates through February 27, 2026, meaning stock on retail shelves and in distributor inventories could still be within the affected date range.
The public-health calculus centers on the FDA’s Class I designation. For healthy adults, the agency notes Listeria can produce short-term symptoms such as fever, headaches, stiffness, nausea, abdominal pain, and diarrhea. Vulnerable populations—young children, the elderly, people with weakened immune systems, and pregnant women—face more severe consequences; infections can be fatal and can lead to miscarriages or stillbirths. At the time the notice was published, no illnesses had been reported in connection with these products.
Expert perspectives and public response
The FDA’s enforcement notice frames the recall as a significant consumer-safety event that warrants immediate action by retailers and consumers. Consumers are advised not to eat any of the listed cream cheese products and to return them to the place of purchase for a full refund. Made Fresh Salads, Inc. has provided a consumer contact line, 1-718-765-0082, available Monday through Friday, 9 a. m. to 5 p. m. ET, for questions.
Institutional messaging from the FDA underscores the agency’s three-tier risk classification framework and its use here to communicate the urgency of removal and disposal. The company’s disclosure that the contaminated mixer part has been removed from service addresses one control point in production, but the Class I upgrade signals the agency’s assessment that consumer exposure remains a credible risk until affected inventory is recovered.
Regional impact and next steps for consumers
The recall’s distribution footprint—direct deliveries to retail stores and distributors in Brooklyn, Queens, the Bronx, and the New York City area—concentrates the immediate public-health response in a dense urban market. Retailers and distributors in that footprint must check inventories for the affected 5-pound tubs with expiration dates through February 27, 2026, and follow recall-return procedures to remove potentially contaminated product from circulation.
Consumers who may possess the recalled tubs are asked not to consume the product and to seek a refund from the place of purchase. For questions or clarifications about whether a given product is included in the recall, the recall notice directs consumers to contact Made Fresh Salads, Inc. at the provided telephone number during business hours, Monday through Friday, 9 a. m. to 5 p. m. ET.
The Cream Cheese Recall Listeria upgrade to Class I sharpens the public-health imperative: will recovery efforts fully remove affected inventory before any illnesses emerge, and how will manufacturers shore up equipment controls to prevent a repeat?
